The first international consensus on mucous membrane pemphigoid

Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators

Lawrence S. Chan, A. Razzaque Ahmed, Grant J. Anhalt, Wolfgang Bernauer, Kevin D. Cooper, Mark J. Elder, Jo David Fine, C. Stephen Foster, Reza Ghohestani, Takashi Hashimoto, Thanh Hoang-Xuan, Gudula Kirtschig, Neil J. Korman, Susan Lightman, Francina Lozada-Nur, M. Peter Marinkovich, Bartly J. Mondino, Catherine Prost-Squarcioni, Roy S. Rogers, Jane F. Setterfield & 6 others Dennis P. West, Fenella Wojnarowska, David T. Woodley, Kim B. Yancey, Detlef Zillikens, John J. Zone

Research output: Contribution to journalArticle

464 Citations (Scopus)

Abstract

Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.

Original languageEnglish (US)
Pages (from-to)370-379
Number of pages10
JournalArchives of Dermatology
Volume138
Issue number3
StatePublished - 2002

Fingerprint

Bullous Pemphigoid
Mucous Membrane
Oral Medicine
Clinical Laboratory Techniques
Ophthalmology
Dermatology
Pharmacology
Delivery of Health Care
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Chan, L. S., Razzaque Ahmed, A., Anhalt, G. J., Bernauer, W., Cooper, K. D., Elder, M. J., ... Zone, J. J. (2002). The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. Archives of Dermatology, 138(3), 370-379.

The first international consensus on mucous membrane pemphigoid : Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. / Chan, Lawrence S.; Razzaque Ahmed, A.; Anhalt, Grant J.; Bernauer, Wolfgang; Cooper, Kevin D.; Elder, Mark J.; Fine, Jo David; Stephen Foster, C.; Ghohestani, Reza; Hashimoto, Takashi; Hoang-Xuan, Thanh; Kirtschig, Gudula; Korman, Neil J.; Lightman, Susan; Lozada-Nur, Francina; Peter Marinkovich, M.; Mondino, Bartly J.; Prost-Squarcioni, Catherine; Rogers, Roy S.; Setterfield, Jane F.; West, Dennis P.; Wojnarowska, Fenella; Woodley, David T.; Yancey, Kim B.; Zillikens, Detlef; Zone, John J.

In: Archives of Dermatology, Vol. 138, No. 3, 2002, p. 370-379.

Research output: Contribution to journalArticle

Chan, LS, Razzaque Ahmed, A, Anhalt, GJ, Bernauer, W, Cooper, KD, Elder, MJ, Fine, JD, Stephen Foster, C, Ghohestani, R, Hashimoto, T, Hoang-Xuan, T, Kirtschig, G, Korman, NJ, Lightman, S, Lozada-Nur, F, Peter Marinkovich, M, Mondino, BJ, Prost-Squarcioni, C, Rogers, RS, Setterfield, JF, West, DP, Wojnarowska, F, Woodley, DT, Yancey, KB, Zillikens, D & Zone, JJ 2002, 'The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators', Archives of Dermatology, vol. 138, no. 3, pp. 370-379.
Chan, Lawrence S. ; Razzaque Ahmed, A. ; Anhalt, Grant J. ; Bernauer, Wolfgang ; Cooper, Kevin D. ; Elder, Mark J. ; Fine, Jo David ; Stephen Foster, C. ; Ghohestani, Reza ; Hashimoto, Takashi ; Hoang-Xuan, Thanh ; Kirtschig, Gudula ; Korman, Neil J. ; Lightman, Susan ; Lozada-Nur, Francina ; Peter Marinkovich, M. ; Mondino, Bartly J. ; Prost-Squarcioni, Catherine ; Rogers, Roy S. ; Setterfield, Jane F. ; West, Dennis P. ; Wojnarowska, Fenella ; Woodley, David T. ; Yancey, Kim B. ; Zillikens, Detlef ; Zone, John J. / The first international consensus on mucous membrane pemphigoid : Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. In: Archives of Dermatology. 2002 ; Vol. 138, No. 3. pp. 370-379.
@article{de2d0598170249d0bee42f1e699a8c45,
title = "The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators",
abstract = "Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.",
author = "Chan, {Lawrence S.} and {Razzaque Ahmed}, A. and Anhalt, {Grant J.} and Wolfgang Bernauer and Cooper, {Kevin D.} and Elder, {Mark J.} and Fine, {Jo David} and {Stephen Foster}, C. and Reza Ghohestani and Takashi Hashimoto and Thanh Hoang-Xuan and Gudula Kirtschig and Korman, {Neil J.} and Susan Lightman and Francina Lozada-Nur and {Peter Marinkovich}, M. and Mondino, {Bartly J.} and Catherine Prost-Squarcioni and Rogers, {Roy S.} and Setterfield, {Jane F.} and West, {Dennis P.} and Fenella Wojnarowska and Woodley, {David T.} and Yancey, {Kim B.} and Detlef Zillikens and Zone, {John J.}",
year = "2002",
language = "English (US)",
volume = "138",
pages = "370--379",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - The first international consensus on mucous membrane pemphigoid

T2 - Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators

AU - Chan, Lawrence S.

AU - Razzaque Ahmed, A.

AU - Anhalt, Grant J.

AU - Bernauer, Wolfgang

AU - Cooper, Kevin D.

AU - Elder, Mark J.

AU - Fine, Jo David

AU - Stephen Foster, C.

AU - Ghohestani, Reza

AU - Hashimoto, Takashi

AU - Hoang-Xuan, Thanh

AU - Kirtschig, Gudula

AU - Korman, Neil J.

AU - Lightman, Susan

AU - Lozada-Nur, Francina

AU - Peter Marinkovich, M.

AU - Mondino, Bartly J.

AU - Prost-Squarcioni, Catherine

AU - Rogers, Roy S.

AU - Setterfield, Jane F.

AU - West, Dennis P.

AU - Wojnarowska, Fenella

AU - Woodley, David T.

AU - Yancey, Kim B.

AU - Zillikens, Detlef

AU - Zone, John J.

PY - 2002

Y1 - 2002

N2 - Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.

AB - Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.

UR - http://www.scopus.com/inward/record.url?scp=0036120880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036120880&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 370

EP - 379

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 3

ER -